Neoadjuvant FOLFIRINOX and IMRT concurrent with FDR-gemcitabine in patients with borderline resectable pancreatic cancer (BRPC).

被引：1
|
作者：
Tran, Nguyen H.
Sahai, Vaibhav
Griffith, Kent A.
Nathan, Hari
Kaza, Ravi
Cuneo, Kyle Clifford
Sonnenday, Christopher J.
Cho, Clifford
Lawrence, Theodore Steven
Zalupski, Mark
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Hlth Syst, Ann Arbor, MI USA
[3] Univ Massachusetts, Mem Med Ctr, Ann Arbor, MI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 04期
关键词：
D O I：
10.1200/JCO.2018.36.4_suppl.381
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
381
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Neoadjuvant chemotherapy with FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy for borderline resectable and resectable pancreatic cancer (PREOPANC-2): A multicenter randomized controlled trial
    Koerkamp, B. Groot
    Janssen, Q. P.
    van Dam, J. L.
    Bonsing, B. A.
    Bos, H.
    Bosscha, K. P.
    Haberkorn, B. C. M.
    de Hingh, I. H. J. T.
    Karsten, T. M.
    Van der Kolk, M. B.
    Liem, M. S. L.
    Loosveld, O. J. L.
    Patijn, G. A.
    van Santvoort, H. C. M.
    de Vos-Geelen, J.
    van der Holt, B.
    Homs, M. Y. V.
    van Tienhoven, G.
    Besselink, M. G.
    Wilmink, H. W.
    ANNALS OF ONCOLOGY, 2023, 34 : S1323 - S1323
  • [32] Neoadjuvant Nab-paclitaxel and Gemcitabine in Borderline Resectable or Locally Advanced Unresectable Pancreatic Adenocarcinoma in Patients Who Are Ineligible for FOLFIRINOX
    Peterson, Shawn L.
    Husnain, Muhammad
    Pollack, Terri
    Pimentel, Agustin
    Loaiza-Bonilla, Arturo
    Westendorf-Overley, Colleen
    Ratermann, Kelley
    Anthony, Lowell
    Desimone, Philip
    Goel, Gaurav
    Kudrimoti, Mahesh
    Dineen, Sean
    Tzeng, Ching-Wei D.
    Hosein, Peter J.
    ANTICANCER RESEARCH, 2018, 38 (07) : 4035 - 4039
  • [33] FOLFIRINOX versus Gemcitabine/nab-Paclitaxel for Neoadjuvant Treatment of Resectable and Borderline Resectable Pancreatic Adenocarcinoma: A Propensity Matched Analysis
    Dhir, M.
    Zenati, M. S.
    Hamad, A.
    Singhi, A. D.
    Bahary, N.
    Hogg, M.
    Zeh, H.
    Zureikat, A.
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : S8 - S8
  • [34] Neoadjuvant therapy for resectable and borderline resectable pancreatic cancer
    Kumar, Rachit
    Jabbour, Salma K.
    JOURNAL OF RADIATION ONCOLOGY, 2013, 2 (04) : 353 - 367
  • [35] Prognostic Factors for Survival in Patients Undergoing Curative Resection After Neoadjuvant FOLFIRINOX in Borderline Resectable Pancreatic Cancer
    Barenboim, A.
    Lahat, G.
    Nachmany, I.
    Brazowsk, E.
    Geva, R.
    Wolf, I.
    Golan, T.
    Klausner, J.
    Lubezky, N.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 1) : S135 - S135
  • [36] Optimal adjuvant therapy in patients with borderline resectable and unresectable pancreatic cancer who had received neoadjuvant FOLFIRINOX
    Choi, Jin Ho
    Kim, Min Kyu
    Park, Jin Woo
    Park, Nam Young
    Cho, In Rae
    Lee, Sang Hyub
    Ryu, Ji Kon
    Kim, Yong-Tae
    Paik, Woo Hyun
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 237 - 237
  • [37] Folfirinox versus gemcitabine/nab-paclitaxel for neoadjuvant treatment of resectable and borderline resectable pancreatic adenocarcinoma: A propensity matched analysis.
    Dhir, Mashaal
    Zenati, Mazen S.
    Hamad, Ahmad
    Singhi, Aatur D.
    Bahary, Nathan
    Hogg, Melissa Ellen
    Zeh, Herbert
    Zureikat, Amer H.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [38] Neoadjuvant Therapy for Resectable or Borderline Resectable Pancreatic Cancer
    Lee, Sang Hoon
    KOREAN JOURNAL OF GASTROENTEROLOGY, 2024, 84 (03) : 103 - 110
  • [39] Neoadjuvant Chemoradiotherapy for Resectable and Borderline Resectable Pancreatic Cancer
    Attaallah, Wafi
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (28) : 3346 - +
  • [40] Cost-effectiveness of neoadjuvant FOLFIRINOX versus gemcitabine plus nab-paclitaxel in locally advanced/borderline resectable pancreatic cancer patients.
    Ingram, Myles
    Lauren, Brianna N.
    Pumpalova, Yoanna S.
    Manji, Gulam Abbas
    Bates, Susan Elaine
    Hur, Chin
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345